A retrospective analysis of treatment-related hospitalization costs of pediatric, adolescent, and young adult acute lymphoblastic leukemia.

Risk of hospitalization among survivors of childhood and adolescent acute lymphoblastic leukemia compared to siblings and a general population sample. Cancer Epidemiol (2017) 0.75

Treatment of acute lymphoblastic leukemia. N Engl J Med (2006) 11.30

Use of intensive care at the end of life in the United States: an epidemiologic study. Crit Care Med (2004) 9.06

Pharmacogenomics--drug disposition, drug targets, and side effects. N Engl J Med (2003) 7.23

Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol (1996) 5.09

Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group. J Clin Oncol (2012) 5.08

Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood (2007) 3.79

Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial. Lancet Oncol (2014) 2.48

Are high drug prices for hematologic malignancies justified? A critical analysis. Cancer (2015) 2.35

Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL. Blood (2013) 2.34

Productivity costs of cancer mortality in the United States: 2000-2020. J Natl Cancer Inst (2008) 2.23

Relapsed childhood acute lymphoblastic leukaemia. Lancet Oncol (2013) 1.88

Site of oncologic specialty care for older adolescents in Utah. J Clin Oncol (2007) 1.87

Childhood cancer survival in Europe and the United States. Cancer (2002) 1.59

Genetics of glucocorticoid-associated osteonecrosis in children with acute lymphoblastic leukemia. Blood (2015) 1.57

Cost-effectiveness of treatment of childhood acute lymphoblastic leukemia with chemotherapy only: the influence of new medication and diagnostic technology. Pediatr Blood Cancer (2011) 1.54

Can health care costs be reduced by limiting intensive care at the end of life? Am J Respir Crit Care Med (2002) 1.46

A 50-year journey to cure childhood acute lymphoblastic leukemia. Semin Hematol (2013) 1.32

Central nervous system disease in hematologic malignancies: historical perspective and practical applications. Semin Oncol (2009) 1.21

Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children's Oncology Group study AALL0232. Blood (2015) 1.08

Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients. Cancer (1999) 1.08

A mixed method approach to describe the out-of-pocket expenses incurred by families of children with cancer. Pediatr Blood Cancer (2012) 0.97

Outpatient and oral antibiotic management of low-risk febrile neutropenia are effective in children--a systematic review of prospective trials. Support Care Cancer (2012) 0.97

Impact of aggressive management and palliative care on cancer costs in the final month of life. Cancer (2015) 0.96

Risk of hospitalization for survivors of childhood and adolescent cancer. Cancer Epidemiol Biomarkers Prev (2014) 0.96

A revised definition for cure of childhood acute lymphoblastic leukemia. Leukemia (2014) 0.95

Severe hypertriglyceridaemia during therapy for childhood acute lymphoblastic leukaemia. Eur J Cancer (2014) 0.87

Trends and issues in oncology costs. Expert Rev Pharmacoecon Outcomes Res (2013) 0.87

Cardiovascular disease in adult survivors of childhood cancer. Annu Rev Med (2015) 0.87

Cost-analysis of treatment of childhood acute lymphoblastic leukemia with asparaginase preparations: the impact of expensive chemotherapy. Haematologica (2013) 0.86

Treatment of acute lymphoblastic leukaemia : a new era. Drugs (2007) 0.86

The Children's Oncology Group Childhood Cancer Research Network (CCRN): case catchment in the United States. Cancer (2014) 0.86

Financial Burden of Pediatric Cancer for Patients and Their Families. J Oncol Pract (2014) 0.84

The diagnostic value of interleukin-8 for the detection of bacteremia in pediatric hematopoietic stem cell recipients with febrile neutropenia. Transplantation (2014) 0.83

Ciprofloxacin and amoxicillin as continuation treatment of febrile neutropenia in pediatric cancer patients. Med Pediatr Oncol (2003) 0.82

A new approach to analyse longitudinal epidemiological data with an excess of zeros. BMC Med Res Methodol (2013) 0.82

Statewide Longitudinal Hospital Use and Charges for Pediatric and Adolescent Patients With Cancer. J Oncol Pract (2015) 0.82

Geography and the burden of care in pediatric cancers. Pediatr Blood Cancer (2014) 0.80

Risk factors for relapse in childhood acute lymphoblastic leukemia: prediction and prevention. Expert Rev Hematol (2014) 0.79

ReCAP: Gaps in Insurance Coverage for Pediatric Patients With Acute Lymphoblastic Leukemia. J Oncol Pract (2015) 0.79

Outpatient management of febrile neutropenia in children with cancer. Pediatr Rep (2011) 0.79

Ciprofloxacin in treatment of fever and neutropenia in pediatric cancer patients. Pediatr Infect Dis J (2003) 0.77

The economic burden of caregiving on families of children and adolescents with cancer: a population-based assessment. Pediatr Blood Cancer (2013) 0.76

Neonatal Magnesium Levels Between 24 and 48 Hours of Life and Outcomes for Epilepsy and Motor Impairment in Premature Infants. Pediatr Neurol (2016) 0.75